360 Photos | 360 View Photos

This is a view from the control room for the dedicated cardiac 1.5T MRI system recently installed at Baylor, Scott ...

Home August 28, 2018
Home
News

Medtronic plc announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures. The study evaluated patients with symptomatic persistent atrial fibrillation (AF) treated with the Medtronic Arctic Front Advance Cryoballoon, and the results were presented at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-28 in Munich.

Home August 28, 2018
Home
News | Sudden Cardiac Arrest

A new study showed a change in the type of breathing tube paramedics use to resuscitate patients with sudden cardiac arrest can significantly improve the odds of survival and save thousands of lives. More than 90 percent of Americans who experience sudden cardiac arrest die before, or soon after, reaching a hospital.

Home August 28, 2018
Home
News | Stroke

iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging platform for cerebrovascular imaging, with 520 currently installed. RAPID technology assists physicians in the analysis of brain images using automated tools for CT ASPECTS, computed tomography (CT) angiography, CT perfusion, magnetic resonance (MR) diffusion and perfusion for more than 85,000 stroke cases per year. RAPID is also currently deployed in six multi-center clinical trials globally.

Home August 28, 2018
Home
News | Pharmaceuticals

Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with hypertension after more than a decade, according to late breaking results from the ASCOT Legacy study. The results were presented at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-29 in Munich, Germany, and published in The Lancet.

Home August 27, 2018
Home
News | Cardiac Diagnostics

Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany. The CADScor System has been validated clinically to rule out CAD with 96-97 percent negative predictive value. The device is gaining interest and increased use across Germany and Denmark, key Swedish hospitals are testing the system and expansion in other European countries is under way. At ESC 2018, both in the exhibition booth and at a special session Aug. 28, there will be opportunities to get first-hand information about the CADScor System and to meet experts with experience from using the system in clinical practice.

Home August 27, 2018
Home
News | ECG Wireless Remote Access

U.S. Expeditions and Explorations (USX) and Cardiac Insight Inc. announced the successful completion of an expedition on North America’s highest mountain, Denali, to gather data on sudden cardiac death (SCD) risk at high altitudes using the Cardea Solo device.

Home August 24, 2018
Home
News | Cardiac Diagnostics

The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular Health (MACH) trial. The decision is based on concerns about the study design that cast doubt on its ultimate credibility. This includes whether the study would effectively address other significant consequences of moderate alcohol intake, such as cancer.

Home August 24, 2018
Home
News | Mobile Devices

Cerner recently collaborated with Duke Clinical Research Institute (DCRI) to develop an atherosclerotic cardiovascular disease (ASCVD) Risk Calculator app. The app was designed as a tool to increase communication between the patient and their doctor about ways to live a healthier life and risk factors for heart disease and stroke.

Home August 24, 2018
Home
Technology | Balloon Catheter

W. L. Gore & Associates Inc. (Gore) announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Gore Molding & Occlusion Balloon. The compliant polyurethane balloon catheter is designed to assist in the expansion of self-expanding stent grafts or to temporarily occlude large-diameter vessels. The device also received approval from the Japanese Ministry of Health, Labour and Welfare, and receipt of CE Mark. It meets all endovascular aortic repair (EVAR) procedural requirements, according to Gore – a single balloon that replaces the need for multiple molding and occlusion balloons.

Home August 23, 2018
Home
Technology | Cardiovascular Ultrasound

August 22, 2018 — Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on ...

Home August 22, 2018
Home
News | Stroke

Breastfeeding is not only good for babies, according to new research in the Journal of the American Heart Association. The research indicates there is growing evidence breastfeeding may also reduce the risk for stroke in post-menopausal women who reported breastfeeding at least one child.

Home August 22, 2018
Home
Videos | Nuclear Imaging

Kim A. Williams, Sr., M.D., MACC, MASNC, FAHA, FESC, cardiology division chief and James B. Herrick professor at Rush ...

Home August 22, 2018
Home
Videos | Nuclear Imaging

Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology at ...

Home August 21, 2018
Home
The Edwards Lifesciences Cardioband Tricuspid Valve Reconstruction System received the European CE mark approval in May.
Feature | Heart Valve Technology | Jeff Zagoudis

The tricuspid valve has been dubbed “the forgotten valve” by many practitioners in the interventional cardiology space ...

Home August 21, 2018
Home
Subscribe Now